Home › Funds › Gray Foundation › NBIX
Gray Foundation position in NBIX
NEUROCRINE BIOSCIENCES INC · Health Care
Gray Foundation reported holding 37,800 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 1.25% of its reported portfolio and ranking #7 among its reported holdings. Gray Foundation has disclosed NBIX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-11 · Source: SEC EDGAR Form 13F-HR
How Gray Foundation's NBIX position evolved
Gray Foundation first disclosed a stake in NBIX in Q4 2025 at 37,800 shares (US$5.4M). The position peaked in Q2 2026 at 37,800 shares, worth US$6.4M. Across 4 filings, Gray Foundation held the position steady without any share-count change. The most recent filing (Q3 2026) shows 37,800 shares valued at US$5.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 37.80K | $5.36M | New |
| Q1 2026 | 37.80K | $4.98M | Hold |
| Q2 2026 | 37.80K | $6.37M | Hold |
| Q3 2026 | 37.80K | $5.36M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NBIX and 13F data
NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 34 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$393.7M), Two Sigma Investments (US$349.9M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NBIX
- Renaissance Technologies 2.34M sh · $393.68M · Q2 2026
- Two Sigma Investments 2.08M sh · $349.92M · Q2 2026
- Vestal Point Capital, LP 1.88M sh · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 1.27M sh · $213.69M · Q2 2026
- IEQ CAPITAL, LLC 640.30K sh · $107.91M · Q2 2026
More on Gray Foundation
FAQ
How long has Gray Foundation held NBIX?
Gray Foundation has disclosed NBIX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Gray Foundation's current position in NBIX?
As of Q3 2026, Gray Foundation holds 37.80K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $5.36M, representing 1.25% of its reported portfolio and ranking #7.
Has Gray Foundation been buying or selling NBIX?
In the latest 13F filing (Q3 2026), Gray Foundation held unchanged its position in NBIX. The position peaked in Q2 2026 at 37.80K shares.
Which other funds hold NBIX?
Other major institutional holders of NBIX include Renaissance Technologies, Two Sigma Investments, Vestal Point Capital, LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.